Funded Tech Companies

Leuko

Leuko, operating out of Boston, received equity investments from Nina Capital, IAG Capital Partners and HTH VC.

Company Overview

Company Name
Leuko
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
8 St. Mary's St. 613
Boston, MA 02215
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Improving quality of life and outcomes for chemotherapy patients and others at risk of severe neutropenia, through the first noninvasive white cell monitor. This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.
Profile
Leuko LinkedIn Company Profile
Social Media
Leuko Company Twitter Account
Company News
Leuko News
Facebook
Leuko on Facebook
YouTube
Leuko on YouTube
Last Transaction
9/23/2022

Financing History

Date
Type
Amount
Venture Equity
$5,000,000
Venture Equity
$1,800,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Carlos Gonzalez
  Carlos Gonzalez LinkedIn Profile  Carlos Gonzalez Twitter Account  Carlos Gonzalez News  Carlos Gonzalez on Facebook
Chief Medical Officer
Alvaro Sanchez-Ferro
  Alvaro Sanchez-Ferro LinkedIn Profile  Alvaro Sanchez-Ferro Twitter Account  Alvaro Sanchez-Ferro News  Alvaro Sanchez-Ferro on Facebook
Chief Technical Officer
Ian Butterworth
  Ian Butterworth LinkedIn Profile  Ian Butterworth Twitter Account  Ian Butterworth News  Ian Butterworth on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Leucine | LeukoDx

 

Share this article

 


About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary